US drug firm Johnson & Johnson has been told to pay $US8bn in punitive damages to a man over claims he was not warned that an anti-psychotic drug could lead to breast growth.
BBC News reports a Philadelphia jury made the award to 26-year-old Nicholas Murray whose case was one of the thousands pending in the state.
His lawyers argued J&J's subsidiary Janssen put "profits over patients" in marketing the drug Risperdal.
J&J will appeal the ruling, which it said was "grossly disproportionate".
The company is facing a series of complaints in the US for allegedly failing to properly warn of Risperdal's side effects.
The US giant is also facing court challenges over baby powder allegedly tainted with asbestos.
Those cases are in addition to an ongoing legal battle over its role in the US opioid addiction crisis.
BBC
